This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Food and Drug Administration (FDA) for the use of its QP-Prostate MRI software to help detect and diagnose prostate cancer. hospitals and pharmaceutical companies and that QP-Prostate was initially cleared in 2021 for automated segmentation of prostate regions. Quibim has received clearance from the U.S.
In a stunning development, a European Union regulatory body on March 10 recommended that four gadolinium-based contrast agents (GBCAs) for MRI scans be pulled off the market due to concerns about gadolinium remaining in the body years after scans occur.
Springbok is building a new standard in muscle health with its MRI-based AI muscle analysis technology that is used widely throughout elite sports, human performance and life sciences. Sarcopenia is an inevitable symptom of aging, and yet there are no pharmaceutical interventions to prevent or address the issue.
Quibim has closed a $50 million series A financing round to support strategic collaborations with hospitals and pharmaceutical companies in the U.S. However, as the volume of whole-body scans and related imaging data grows, in the coming years Quibim models will analyze the entire body, the company noted.
mmol/kg gadobutrol (Gadavist) focused on adult patients referred for contrast-enhanced MRI of certain body regions. mmol/kg gadobutrol (Gadavist) focused on adult patients referred for contrast-enhanced MRI of certain body regions. This multinational, crossover (within-patient), double-blind comparison of the safety and efficacy of 0.05
Using public-private partnership hospitals will be set up with a financial contribution from Government of India -GOI to extend facilities to 112 Aspirational Districts making ‘Ayushman Bharat’ viable for weaker sections. 5 lakhs under the ‘Ayushman Bharat’ scheme has raised the preference for private hospitals.
announced the acquisition’s close and addition of MIM Software’s imaging analytics and digital workflow solutions as a part of its leading global medical technology, pharmaceutical diagnostics, and digital portfolio.
A recruiter at a hospital may find themselves looking for talent in several industries that fall under the healthcare sector. MRI Network is a leading global executive search firm with experience across all industries. At MRI Network, we can find long-term, skilled talent for every level and facet of your healthcare organization.
Hospitals and healthcare organizations are currently struggling to fill many positions. Since 1965, MRI Network has been a global force in effectively placing talent. MRI Network offers various options for recruitment, including executive search, retained search, engaged search, and contingency search.
Imagine going in for a diagnostic MRI scan and coming out with a progressive, irreversible, and potentially fatal disease. Louis hospital. Last week, attorneys for a Cleveland man announced they had filed suit against a gadolinium manufacturer, claiming that he developed NSF from an injection of gadolinium MRI contrast.
Echocardiography (Transesophageal > Transthoracic) is the diagnostic test of choice followed by cardiac MRI and CT scans to help better visualize the intracardiac mass for preoperative planning [2,3]. CMs can be differentiated from a thrombus on CT by assessing for size, origin, shape, mobility, and prolapse.
We organize all of the trending information in your field so you don't have to. Join 5,000 users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content